Prelude Capital Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,914
| Closed | -$55K | – | 1944 |
|
|
2019
Q3 | $55K | Buy |
+2,914
| New | +$55K | ﹤0.01% | 733 |
|
|
2018
Q1 | – | Sell |
-48,767
| Closed | -$558K | – | 1683 |
|
|
2017
Q4 | $558K | Sell |
48,767
-6,052
| -11% | -$69.2K | 0.04% | 342 |
|
|
2017
Q3 | $672K | Sell |
54,819
-31,873
| -37% | -$391K | 0.06% | 275 |
|
|
2017
Q2 | $993K | Buy |
86,692
+71,504
| +471% | +$819K | 0.09% | 196 |
|
|
2017
Q1 | $316K | Buy |
+15,188
| New | +$316K | 0.03% | 384 |
|
|
2016
Q4 | – | Sell |
-16,162
| Closed | -$530K | – | 1839 |
|
|
2016
Q3 | $530K | Buy |
+16,162
| New | +$530K | 0.06% | 266 |
|
|
2016
Q1 | – | Sell |
-7,000
| Closed | -$231K | – | 1573 |
|
|
2015
Q4 | $231K | Buy |
7,000
+5,800
| +483% | +$191K | 0.04% | 448 |
|
|
2015
Q3 | $39K | Hold |
1,200
| – | – | 0.01% | 1039 |
|
|
2015
Q2 | $64K | Buy |
1,200
+500
| +71% | +$26.7K | 0.01% | 987 |
|
|
2015
Q1 | $20K | Sell |
700
-400
| -36% | -$11.4K | ﹤0.01% | 1679 |
|
|
2014
Q4 | $32K | Buy |
+1,100
| New | +$32K | ﹤0.01% | 1517 |
|